Aclaris Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACRS and other ETFs, options, and stocks.

About ACRS

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments.

CEO

Neal S. Walker

CEONeal S. Walker

Employees

Employees64

Headquarters

Wayne, Pennsylvania

HeadquartersWayne, Pennsylvania

Founded

2012

Founded2012

Employees

Employees64

ACRS Key Statistics

Market cap

276.25M

Market cap276.25M

Price-Earnings ratio

-1.87

Price-Earnings ratio-1.87

Dividend yield

—

Dividend yield—

Average volume

1.59M

Average volume1.59M

High today

—

High today—

Low today

—

Low today—

Open price

$2.65

Open price$2.65

Volume

3.22K

Volume3.22K

52 Week high

$5.17

52 Week high$5.17

52 Week low

$1.05

52 Week low$1.05

ACRS News

Simply Wall St 4d

Revenues Not Telling The Story For Aclaris Therapeutics, Inc. After Shares Rise 31%

Aclaris Therapeutics, Inc. ( ) shares have continued their recent momentum with a 31% gain in the last month alone. Looking back a bit further, it's encouraging...

Analyst ratings

88%

of 8 ratings

Buy

87.5%

Hold

12.5%

Sell

People also own

Based on the portfolios of people who own ACRS. This list is generated using Robinhood data, and it’s not a recommendation.